Search for: "State v. Sessions" Results 3981 - 4000 of 6,577
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jun 2014, 6:36 am
The second Ordinance seeks to amend the Andhra Pradesh Reorganisation Act passed by Parliament earlier this year to carve out India’s 29th State- Telangana from the erstwhile undivided State of Andhra Pradesh.[2] This Ordinance makes certain amendments to the territories covered by the Khammam district under this State bifurcation law. [read post]
1 Jun 2014, 4:00 am by Administrator
At the mediation session, Dow Chemical offered to settle for $7 million. [read post]
31 May 2014, 8:29 am
This too also appears to be untrue.Bernie also filed an amended complaint which expressly states that Tacopina sat through five proffer sessions with the government. [read post]
31 May 2014, 8:26 am by Michael Lumer
This too also appears to be untrue.Bernie also filed an amended complaint which expressly states that Tacopina sat through five proffer sessions with the government. [read post]
31 May 2014, 5:49 am by Tara Hofbauer
Mark Martins’ statements before a pre-trial motions hearing in the case of United States v. [read post]
30 May 2014, 9:10 am by Wells Bennett
This week, the Judge in United States v. [read post]
28 May 2014, 6:49 am by Wells Bennett
Down at Guantanamo, pre-trial proceedings will resume this morning in the military commission case of United States v. [read post]
28 May 2014, 4:18 am by Kevin LaCroix
”  Davidoff noted that the Delaware Supreme Court’s decision did not state that it was applicable to stock corporations, but it did state that whether or not a fee-shifting by law is enforceable “depends on the manner in which it was adopted and the circumstances in which it was invoked. [read post]
27 May 2014, 4:58 pm by Wells Bennett
Mark Martins, had this to say on the eve of a pre-trial motions hearing in United States v. [read post]
22 May 2014, 3:58 pm by Aaron Barkoff
The agenda includes the following presentations: Minimizing the Uncertainty Surrounding the Untested Pathway: Insight Into FDA's Current Position and Initiatives Regarding Biosimilars Predicting Follow-On Entry and Evaluating the Risk and Commercial Opportunity in the Emerging Biosimilar Landscape New Kid No More: Evolution in Biosimilars Science and Regulations The Holy Grail for Biosimilars: Meeting FDA's Requirements for Biosimilarity and the Heightened Standard of Interchangeability… [read post]